Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedJun 01, 2025
DataAggregated Company Financials
Companies33
  • 7D8.2%
  • 3M17.5%
  • 1Y34.6%
  • YTDn/a

The Biotech industry is up 8.2% in the last week, with GNI Group up 44%. This means that the industry has gained 35% over the past year. Looking forward, earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 01 Jun 2025JP¥1.2tJP¥214.8b-JP¥40,596,253,000.0015.3x-29.6x5.6x
Tue, 29 Apr 2025JP¥1.0tJP¥207.8b-JP¥39,029,205,000.0014.6x-26.5x5x
Thu, 27 Mar 2025JP¥1.0tJP¥207.8b-JP¥39,285,917,000.0015.9x-26.6x5x
Sat, 22 Feb 2025JP¥1.1tJP¥207.4b-JP¥38,725,293,000.0015.6x-27.7x5.2x
Mon, 20 Jan 2025JP¥995.1bJP¥207.3b-JP¥13,514,452,000.0020.1x-73.6x4.8x
Wed, 18 Dec 2024JP¥1.1tJP¥206.4b-JP¥9,855,899,000.0021.9x-108.4x5.2x
Fri, 15 Nov 2024JP¥1.1tJP¥215.7b-JP¥6,576,514,000.0022.8x-167.7x5.1x
Sun, 13 Oct 2024JP¥1.1tJP¥214.3b-JP¥2,078,229,000.0021.1x-526x5.1x
Tue, 10 Sep 2024JP¥1.0tJP¥210.1b-JP¥469,229,000.0015.7x-2203.5x4.9x
Thu, 08 Aug 2024JP¥962.8bJP¥187.5b-JP¥16,096,875,000.0053.7x-59.8x5.1x
Sat, 06 Jul 2024JP¥1.0tJP¥187.7b-JP¥15,773,284,000.0091.4x-64.3x5.4x
Mon, 03 Jun 2024JP¥807.8bJP¥195.7b-JP¥14,113,047,000.0093.9x-57.2x4.1x
Wed, 01 May 2024JP¥806.9bJP¥198.9b-JP¥14,917,877,000.0046.8x-54.1x4.1x
Fri, 29 Mar 2024JP¥752.5bJP¥194.2b-JP¥15,458,035,000.0060.3x-48.7x3.9x
Sun, 25 Feb 2024JP¥807.8bJP¥196.2b-JP¥18,778,997,000.0065.3x-43x4.1x
Tue, 23 Jan 2024JP¥776.5bJP¥222.3b-JP¥12,604,827,000.0017.1x-61.6x3.5x
Thu, 21 Dec 2023JP¥762.8bJP¥224.2b-JP¥12,970,409,000.0017x-58.8x3.4x
Sat, 18 Nov 2023JP¥774.1bJP¥220.1b-JP¥9,607,487,000.0016.9x-80.6x3.5x
Mon, 16 Oct 2023JP¥787.0bJP¥223.0b-JP¥14,478,735,000.0022.7x-54.4x3.5x
Wed, 13 Sep 2023JP¥881.8bJP¥225.3b-JP¥17,478,085,000.0027.1x-50.4x3.9x
Fri, 11 Aug 2023JP¥875.3bJP¥218.7b-JP¥22,219,491,000.0051x-39.4x4x
Sun, 09 Jul 2023JP¥939.3bJP¥223.0b-JP¥19,224,669,000.0056.9x-48.9x4.2x
Tue, 06 Jun 2023JP¥976.6bJP¥218.4b-JP¥25,405,670,000.0038.9x-38.4x4.5x
Thu, 04 May 2023JP¥892.4bJP¥218.2b-JP¥20,061,938,000.0020.8x-44.5x4.1x
Sat, 01 Apr 2023JP¥914.1bJP¥218.3b-JP¥21,583,164,000.0021.3x-42.4x4.2x
Mon, 27 Feb 2023JP¥935.9bJP¥216.2b-JP¥18,991,580,000.0021x-49.3x4.3x
Wed, 25 Jan 2023JP¥946.7bJP¥186.8b-JP¥24,722,604,000.0040.2x-38.3x5.1x
Fri, 23 Dec 2022JP¥859.4bJP¥186.8b-JP¥24,723,433,000.0039.4x-34.8x4.6x
Sun, 20 Nov 2022JP¥908.6bJP¥182.1b-JP¥23,616,027,000.0047.6x-38.5x5x
Tue, 18 Oct 2022JP¥859.1bJP¥176.5b-JP¥24,974,270,000.0043.1x-34.4x4.9x
Thu, 15 Sep 2022JP¥904.2bJP¥176.4b-JP¥24,682,270,000.0048.3x-36.6x5.1x
Sat, 13 Aug 2022JP¥944.7bJP¥173.9b-JP¥20,080,889,000.0021.1x-47x5.4x
Mon, 11 Jul 2022JP¥912.6bJP¥171.3b-JP¥16,112,943,000.0020.8x-56.6x5.3x
Wed, 08 Jun 2022JP¥868.6bJP¥171.2b-JP¥17,305,721,000.0020x-50.2x5.1x
Price to Earnings Ratio

-50.2x


Total Market Cap: JP¥868.6bTotal Earnings: -JP¥17,305,721,000.00Total Revenue: JP¥171.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -122.6x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Biotechnology industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.6x is lower than the industry's current PS ratio of 5.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 7.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market2.34%
Healthcare1.79%
Biotech8.23%
Biotech8.23%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2160 GNI GroupJP¥4.29k44.4%
+JP¥66.2b		94.7%PS9.4x
4593 Healios K.KJP¥455.0038.3%
+JP¥12.8b		188.0%PS78.5x
4587 PeptiDreamJP¥1.75k4.8%
+JP¥10.4b		-10.9%PE15.3x
4974 Takara BioJP¥791.004.8%
+JP¥4.3b		-22.7%PE91.5x
219A HeartseedJP¥2.63k5.0%
+JP¥2.8b		n/aPS67.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4563

JP¥67.00

AnGes

7D

-1.5%

1Y

45.7%

4587

JP¥1,754.00

PeptiDream

7D

4.8%

1Y

-10.9%

4588

JP¥624.00

Oncolys BioPharma

7D

20.9%

1Y

-5.0%

Is Oncolys BioPharma (TSE:4588) Using Debt In A Risky Way?

May 29
Is Oncolys BioPharma (TSE:4588) Using Debt In A Risky Way?

4592

JP¥3,015.00

SanBio

7D

-4.7%

1Y

495.8%

2160

JP¥4,290.00

GNI Group

7D

44.4%

1Y

94.7%

219A

JP¥2,626.00

Heartseed

7D

5.0%

1Y

n/a

Here's Why We're Not At All Concerned With Heartseed's (TSE:219A) Cash Burn Situation

May 26
Here's Why We're Not At All Concerned With Heartseed's (TSE:219A) Cash Burn Situation

4584

JP¥214.00

Kidswell Bio

7D

20.9%

1Y

71.2%

Kidswell Bio Corporation (TSE:4584) Surges 44% Yet Its Low P/S Is No Reason For Excitement

May 22
Kidswell Bio Corporation (TSE:4584) Surges 44% Yet Its Low P/S Is No Reason For Excitement

4974

JP¥791.00

Takara Bio

7D

4.8%

1Y

-22.7%

Some Investors May Be Willing To Look Past Takara Bio's (TSE:4974) Soft Earnings

May 22
Some Investors May Be Willing To Look Past Takara Bio's (TSE:4974) Soft Earnings

4593

JP¥455.00

Healios K.K

7D

38.3%

1Y

188.0%

4894

JP¥5,930.00

Cuorips

7D

-2.6%

1Y

17.9%

4564

JP¥22.00

OncoTherapy Science

7D

-4.3%

1Y

0%

4594

JP¥40.00

BrightPath Biotherapeutics

7D

-2.4%

1Y

-31.0%

7777

JP¥148.00

3-D Matrix

7D

13.0%

1Y

7.2%

7776

JP¥516.00

CellSeed

7D

-4.4%

1Y

99.2%

4575

JP¥1,007.00

CanBas

7D

-21.4%

1Y

97.8%

CanBas (TSE:4575) Is In A Good Position To Deliver On Growth Plans

Apr 08
CanBas (TSE:4575) Is In A Good Position To Deliver On Growth Plans